NORTHRIDGE, Calif., Nov. 5, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that Chad Spooner, EVP, Chief Financial Officer, will discuss and answer questions on the
NORTHRIDGE, Calif., Nov. 4, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that it expects to report financial results on Tuesday, November 24, 2026, for its second
NORTHRIDGE, Calif., Nov. 3, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced the appointment of David Segal, M.D., as Chief Medical Officer. Dr. Segal succeeds Robert
NORTHRIDGE, Calif., Oct. 15, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED) today announced the completion of its separation from Medtronic plc ((", Medtronic", , NYSE:MDT), marking its first day as a fully
GALWAY, Ireland, Oct. 15, 2026 /PRNewswire/ -- Medtronic plc ((Medtronic, NYSE:MDT) today announced the completion of its separation of MiniMed Group, Inc. ((MiniMed, NASDAQ:MMED)."I'm incredibly proud of what
GALWAY, Ireland, Oct. 14, 2026 /PRNewswire/ -- Medtronic plc ((Medtronic, NYSE:MDT) today announced the final results of its previously announced offer to exchange shares of common stock of MiniMed Group, Inc.
GALWAY, Ireland, Oct. 12, 2026 /PRNewswire/ -- Medtronic plc ((Medtronic, NYSE:MDT) today announced that, based on preliminary results, its previously announced offer to exchange shares of common stock of MiniMed Group,
GALWAY, Ireland, Oct. 7, 2026 /PRNewswire/ -- Medtronic plc ((Medtronic, NYSE:MDT) today announced the final exchange ratio for its previously announced offer to exchange outstanding Medtronic ordinary shares for shares
Six-month randomized trial found 8.1 percentage points more Time in Range and 0.6 percentage points lower HbA1c among higher responders.NORTHRIDGE, Calif., Oct. 5, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global
NORTHRIDGE, Calif., Sept. 28, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that Sheila Denton has been named General Counsel & Corporate Secretary.
NORTHRIDGE, Calif., Sept. 14, 2026 /PRNewswire/ -- MiniMed (NASDAQ:MMED) announced that it has filed a Form S-4 Registration Statement today with the Securities and Exchange Commission (the "SEC") in connection
Medtronic shareholders can exchange their Medtronic ordinary shares for shares of MiniMedProvides Medtronic shareholders with option for a generally tax-free exchange for U.S. federal income tax purposesGALWAY, Ireland,
Strong start to fiscal year with net sales of $843 million growing 17% as reported and 16% organicU.S. net sales growth accelerated to 13%; continued robust international net sales growth of 18% as reported, 17%
NORTHRIDGE, Calif., Aug. 25, 2026 /CNW/ -- MiniMed (NASDAQ:MMED), a global leader in diabetes technology, today announced that management will participate in fireside chats at the following investor conferences:
MiniMed Flex™ with Instinct, made by Abbott, combines discreet design, up to 15 days of sensor wear and proven automation to reduce the work and interruptions of diabetes management NORTHRIDGE, Calif., Aug. 17, 2026
